ArticleAsia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology2025
Comparison of clinical outcomes of superior capsular reconstruction and reverse shoulder arthroplasty for irreparable rotator cuff tears in patients aged 65 and older: A propensity score-matched study.
Article in Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objective: In young patients with massive irreparable rotator cuff tears (MRCTs), superior capsular reconstruction (SCR) is a viable surgical treatment option, whereas SCR and reverse shoulder arthroplasty (RSA) are reliable treatments for irreparable MRCTs in patients aged >65 years. This study aimed to compare the outcomes of arthroscopic SCR and RSA in patients with MRCTs without arthritis aged ≥65. Methods: This retrospective comparative study included 202 patients ≥65 years old with irreparable MRCTs who had undergone either SCR using a 3-4 mm single-layer human acellular dermal matrix or RSA between January 2017 and December 2021. All patients underwent at least 2 years of postoperative follow-up. Propensity score matching was performed based on age, sex, dominant-arm involvement, follow-up duration, body mass index, pseudoparalysis, bone mineral density, global fatty degeneration index, and rotator cuff tear size. A total of 44 matched patients (22 with SCR and 22 with RSA) were included in the analysis. Clinical outcomes were assessed using the visual analog scale (VAS) for pain, American Shoulder and Elbow Surgeons (ASES) score, Constant score, Single Assessment Numeric Evaluation (SANE), and active range of motion (ROM). Postoperative radiological evaluations were performed to assess healing failure. Results: No significant differences were observed in the preoperative demographic data, clinical outcomes, or active ROM between the SCR and RSA groups. At the final follow-up, significant improvements in pain, ROM, and functional outcomes were observed in both groups. However, the SCR group had significantly higher ASES scores (88.6 ± 7.5 vs. 81.0 ± 12.0; Conclusion: SCR and RSA resulted in reliable improvements 2 years post-surgery in patients aged >65 years without glenohumeral joint arthritis. However, SCR provided superior outcomes in terms of forward flexion, internal rotation, and functional scores. These results suggest SCR as a more effective treatment option than RSA for irreparable MRCT in this population. Level of evidence: Level III, Retrospective comparative study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.